Homeodomain-only protein X (HOPX)

Homeodomain-only protein X (HOPX) is a unique member of the homeodomain family that lacks the characteristic DNA-binding motif, functioning instead as a transcriptional cofactor (UniProt Q9BPY8). It modulates gene expression by interacting with other transcription factors, most notably Serum Response Factor (SRF), and recruiting histone deacetylases (HDACs) to inhibit SRF-dependent transcription (PubMed: 12150911). HOPX plays a critical role in developmental biology, specifically in the differentiation of cardiomyocytes and the maintenance of quiescent stem cell populations in the hair follicle, intestine, and brain (PubMed: 22522588, PubMed: 26030561). In the context of human disease, HOPX is widely recognized as a tumor suppressor that is frequently silenced by promoter hypermethylation in various solid tumors, including colorectal, gastric, and lung cancers (PubMed: 25193496). From a therapeutic perspective, HOPX is primarily targeted indirectly through epigenetic therapies, such as DNA methyltransferase inhibitors like decitabine, which aim to restore its expression in malignant cells (PubMed: 21855917). Its status as a methylated biomarker is increasingly utilized for cancer prognosis and patient stratification. Additionally, its role in cardiac hypertrophy makes it a subject of interest in cardiovascular research, as it acts as a negative regulator of the hypertrophic response (PubMed: 12150912). Developing direct modulators of HOPX remains a challenge due to its lack of a traditional enzymatic pocket, yet its central role in stem cell biology and tumor suppression continues to make it a high-priority target for regenerative medicine and oncology.

Other names

HOPNECC1OB1HMODHomeobox-only proteinNOT

Epigenetic reactivation via DNA methyltransferase inhibition to restore tumor-suppressive function; modulation of Serum Response Factor (SRF) signaling.